ZIC
BSX icon

ZWJ Investment Counsel’s Boston Scientific BSX Stock Holding History

ZWJ Investment Counsel’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2M Sell
590,216
-113,886
-16% -$6.18M 0.81% 42
2026
Q1 		$44.2M Buy
704,102
+133,091
+23% +$10.6M 1.59% 26
2025
Q4 		$54.4M Buy
571,011
+5,997
+1% +$588K 1.96% 18
2025
Q3 		$55.2M Sell
565,014
-738
-0.1% -$76.4K 1.95% 16
2025
Q2 		$60.8M Sell
565,752
-37,879
-6% -$3.83M 2.26% 12
2025
Q1 		$60.9M Sell
603,631
-13,673
-2% -$1.38M 2.48% 9
2024
Q4 		$55.1M Buy
617,304
+1,761
+0.3% +$155K 2.28% 13
2024
Q3 		$51.6M Sell
615,543
-2,755
-0.4% -$217K 2.11% 13
2024
Q2 		$47.6M Buy
618,298
+12,162
+2% +$890K 2.09% 14
2024
Q1 		$41.5M Sell
606,136
-20,464
-3% -$1.32M 1.89% 23
2023
Q4 		$36.2M Sell
626,600
-7,739
-1% -$413K 1.86% 24
2023
Q3 		$33.5M Sell
634,339
-1,380
-0.2% -$72.4K 1.86% 22
2023
Q2 		$34.4M Sell
635,719
-7,710
-1% -$403K 1.8% 24
2023
Q1 		$32.2M Sell
643,429
-10,417
-2% -$491K 1.78% 26
2022
Q4 		$30.3M Buy
653,846
+3,788
+0.6% +$164K 1.71% 27
2022
Q3 		$25.2M Buy
650,058
+22,600
+4% +$907K 1.58% 31
2022
Q2 		$23.4M Buy
627,458
+24,463
+4% +$996K 1.37% 33
2022
Q1 		$26.7M Sell
602,995
-6,397
-1% -$277K 1.41% 35
2021
Q4 		$25.9M Buy
609,392
+14,200
+2% +$597K 1.32% 35
2021
Q3 		$25.8M Buy
595,192
+6,913
+1% +$306K 1.46% 32
2021
Q2 		$25.2M Buy
588,279
+15,232
+3% +$641K 1.45% 33
2021
Q1 		$22.1M Buy
573,047
+14,923
+3% +$565K 1.36% 37
2020
Q4 		$20.1M Buy
558,124
+331,189
+146% +$11.9M 1.36% 29
2020
Q3 		$8.67M Buy
226,935
+127,055
+127% +$4.9M 0.7% 45
2020
Q2 		$3.51M Buy
99,880
+29,980
+43% +$1.08M 0.3% 55
2020
Q1 		$2.28M Buy
+69,900
New +$2.73M 0.2% 70

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ZWJ Investment Counsel's BSX Position: Q2 2026 in Review

ZWJ Investment Counsel reduced its Boston Scientific (BSX) stake by 16% in Q2 2026, selling an estimated $6.18M and leaving 590,216 shares worth $25.2M. The position accounts for 0.81% of the portfolio, ranked #42.

ZWJ Investment Counsel first reported a position in BSX in Q1 2020 and has held it in 26 quarters since. The position peaked at $60.9M in Q1 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • ZWJ Investment Counsel held 590,216 shares of Boston Scientific worth $25.2M as of Q2 2026.
  • ZWJ Investment Counsel sold 113,886 Boston Scientific shares in Q2 2026, an estimated $6.18M.
  • Boston Scientific made up 0.81% of ZWJ Investment Counsel's portfolio in Q2 2026, its #42 holding.
  • ZWJ Investment Counsel first reported a position in Boston Scientific in Q1 2020 and has held it in 26 quarters since.
  • ZWJ Investment Counsel's Boston Scientific position peaked at $60.9M in Q1 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.